A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
Clinical trial NCT03292406 · COMPLETED
Trial details
- NCT number
- NCT03292406
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2020-03-17
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.